FDA and Big Pharma Discuss Updates on Decentralized Clinical Trials
The 2024 DIA conference session on decentralized clinical trials (DCTs) brought together leading experts from various sectors to discuss...
Moe Alsumidaie
FDA on The Exciting Future of Clinical Trial Regulatory Affairs
The 2024 DIA conference hosted a session, Regulatory Affairs of the Future is Now, which was a dynamic and...
FDA on Real-World Data for Clinical Trial Regulatory Safety Studies
The 2024 DIA conference held a session on Harnessing Real-World Data to Generate Real-World Evidence for Clinical Trial Regulatory...
NuView Liquid Biopsy: High Tech, High Impact, High Reliability
In an exclusive interview with Paul Crowe, CEO of NuView, we delve into his perspectives driving the upcoming Phase...
Walmart Continues Commitment to Increase Clinical Trial Access
Following the strategic exit of Walmart Health Centers, Mairi Aybar, Head of the Walmart Healthcare Research Institute (WHRI), continues...
AI in Clinical Trials: Boosting Efficiency and Outcomes
Clinical trials are increasingly complex, posing challenges in predicting protocol changes, managing enrollment, and ensuring data quality. Aaron Mackey,...
How To Achieve Remarkable Results in Oncology Clinical Trials
In this insightful interview, I spoke with Craig Serra, Head, Clinical Research Scientific and Technical Engagement at Flatiron Health,...
Decentralized Clinical Trials: A New Era of Diversity
Decentralized Clinical Trials (DCTs) are revolutionizing clinical research, offering potential improvements in trial efficiency and participant diversity. In a...
DCT Data: Discover Extraordinary Results and Future Trends
Introduction The COVID-19 pandemic has significantly disrupted traditional clinical research practices, accelerating the shift towards Decentralized Clinical Trials (DCTs)....
Eye-Opening Advanced Therapy for Cancer Offers New Hope
We are excited to bring you an insightful conversation with Robert Towarnicki, Co-Founder and CEO of Sirpant Immunotherapeutics. In...